Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-17-051985

Director disposed of 2,614,157 shares (other)

  • Director acquired 320,970 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Woiwode Thomas Director 2017-09-05 Other disposition −1,368,013 2,736,032 I
Woiwode Thomas Director 2017-09-05 Other disposition −8,110 16,224 I
Woiwode Thomas Director 2017-09-05 Other disposition −814,599 1,629,204 I
Woiwode Thomas Director 2017-09-05 Other disposition −23,899 47,801 I
Woiwode Thomas Director 2017-09-05 Other disposition −61,993 123,994 I
Woiwode Thomas Director 2017-09-05 Other disposition −26,491 52,987 I
Woiwode Thomas Director 2017-09-05 Other acquisition +292,529 292,529 I
Woiwode Thomas Director 2017-09-05 Other disposition −292,529 0 I
Woiwode Thomas Director 2017-09-05 Other acquisition +17,283 17,283 I
Woiwode Thomas Director 2017-09-05 Other disposition −17,283 0 I
Woiwode Thomas Director 2017-09-05 Other acquisition +1,240 1,240 I
Woiwode Thomas Director 2017-09-05 Other disposition −1,240 0 I
Woiwode Thomas Director 2017-09-05 Other acquisition +9,918 9,918 D
Loading xslF345X03/doc4.xml…